Corpus Intelligence IC Memo — CLARK MEMORIAL HOSPITAL 2026-04-26 04:06 UTC
IC Memo — CLARK MEMORIAL HOSPITAL
Investment Committee Memorandum | IN | 153 beds | Grade C | EBITDA uplift $12.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CLARK MEMORIAL HOSPITAL

CCN 150009 | CLARK, IN | 153 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CLARK MEMORIAL HOSPITAL is a 153-bed under-performing / distressed in CLARK, IN with $167.6M in net patient revenue and a -14.9% operating margin. The hospital serves a payer mix of 24.2% Medicare, 4.1% Medicaid, and 71.7% commercial.

Thesis: Undervalued. Our ML models identify $12.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.9% to -7.6% (+736bps).

Net Revenue HCRIS$167.6M
Current EBITDA COMPUTED$-25.0M
Operating Margin COMPUTED-14.9%
Occupancy HCRIS57.2%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS22.1%
Distress Probability ML45.8%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
47
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -14.9% places it below the state median. Among 47 size-comparable peers (76-306 beds), the median margin is 6.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (76-306), prioritizing same-state peers. 47 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CLARK MEMORIAL HOSPITAL (Target)IN153$167.6M-14.9%
UNION HOSPITAL INC.IN258$581.9M3.8%
IU HEALTH BLOOMINGTON HOSPITALIN210$529.4M6.2%
REID HOSPITAL & HEALTH CARE SEIN183$487.2M26.1%
IU HEALTH ARNETT HOSPITALIN194$426.2M16.1%
HENDRICKS REGIONAL HEALTHIN130$423.4M-3.6%
IU HEALTH NORTH HOSPITALIN153$413.3M24.2%
FRANCISCAN HEALTH LAFAYETTEIN177$377.7M2.7%
PORTER REGIONAL HOSPITALIN199$370.6M22.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.5M+210bp18mo
Cost to Collect4.5%2.5%$3.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$107K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.5M
Cost to Collect
$3.4M
Denial Rate Reduction
$3.3M
A/R Days Reduction
$2.0M
Clean Claim Rate
$107K
Total EBITDA Uplift$12.3M
Current EBITDA$-25.0M
+ RCM Uplift+$12.3M
Pro Forma EBITDA$-12.7M
Current Margin-14.9%
Pro Forma Margin-7.6%
WC Released (1x)$6.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-38.5M$-41.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-38.5M$-58.4M0.00x-100.0%
Bull Case9.0x11.0x$-34.6M$-30.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-34.6M$-43.1M0.00x-100.0%
Bear Case11.0x10.0x$-42.3M$-90.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-42.3M$-113.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 47 hospitals with 76-306 beds
  • Same-state prioritization (n=48)
  • Comp margins: P25=-8.2% / P50=6.1% / P75=17.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.